Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
4 major types of fungal infections? |
–Superficialand cutaneous mycoses: common; limited to skin, hair, nails –Subcutaneousmycoses: involve skin, subcutaneous tissue, lymphatics –Endemicmycoses: caused by dimorphic fungi; can cause serious disease in both healthy andimmunocompromisedpatients –Opportunisticmycosis: Can cause life-threatening disease in immunosuppressedpatients |
|
Most common etiologic agents of pulmonaryinfection by fungi in healthy hosts, causing over 1 million infections/year inthe U.S.? |
Dimorphic fungi |
|
How do dimorphic fungi grow? |
•Grow as yeast in human tissue and as moldunder some laboratory conditions (typically room temperature) |
|
How does infection by dimorphic fungi occur? |
•Infection results from inhalation ofspores that have mold forms in soil. |
|
What happens once dimorphic fungi settle in the lungs? |
•Within the lungs the spores differentiateinto yeasts or spherules. –Mostlung infections are self-limited and even asymptomatic, however.. –Allcan cause pneumonia and disseminate. |
|
4 types of dimorphic fungi? |
•Blastomyces dermatitidis•Histoplasma capsulatum•Coccidioides immitis•Paracoccidioides brasiliensis |
|
Where is Histoplasma capsulatum endemic to? |
•Endemic in Mississippi and Ohio RiverValleys. |
|
In what conditions does Histoplasma capsulatum grow? |
•Grows in soil; bird droppings |
|
Most common disseminated infection in AIDS patient? |
Histoplasma capsulatum |
|
Clinical manifestations of Histoplasma capsulatum? |
–Asymptomaticpulmonary infection –Respiratoryinfection characterized by fever, chills, cough, chest pain (usually withintense exposure) –Insetting of AIDS: severe disseminateddisease can develop•Pancytopenia (due to bone marrow infiltration) •Mouth/GI ulcers•Skin rash (pustules, nodules)•Mortality up to 10% |
|
Dx for Histoplasma capsulatum? |
–Tissuebiopsy will show oval yeast cells within macrophages –Serology –Urinaryantigen –CXR:infiltrates, mediastinalLAD, cavitarylesions |
|
Treatment for Histoplasma capsulatum? |
•Treatment: Amphotericin for severe disease; Itraconazole otherwise |
|
Erythema nodosum (EN) manifests how? |
Erythema nodosum (EN) manifests as red, tender nodules(“desert bumps”) on extensor surfaces such as the skin over the tibia and ulna. |
|
What kind of hypersensitivity reaction is EN? |
It is a delayed (cell-mediated) hypersensitivity response to fungal antigens |
|
What kind of prognosis does EN indicate? |
Its an indicator of a good prognosis. Indicates that cell-mediatedimmunity is active. |
|
Where is Blastomycesdermatitidis endemic? |
•Endemic in Ohio/Mississippi River Valley, Missouriand Arkansas River basins |
|
In what conditions does Blastomycesdermatitidis grow? |
Grows in moist soil |
|
Clinical manifestations of Blastomycesdermatitidis? |
–Asymptomaticrespiratory illness •50% will have cough, chest pain,sputum production, fever/night sweats which most often resolves spontaneously -Disseminated disease results inulcerated granulomatous lesions of the skin (70%), bone(33%), GU tract (25%) and CNS (10%). Mostcommonly a verrucous lesion. Can also be ulcerated. Gray to violet colored. •Seen in both immunocompetent and immunocompromised |
|
Diagnosis of Blastomyces? |
–CXR: lobar consolidation, multilobarinfiltrates, multiple nodules, etc. –Tissuebiopsy: thick-walled yeast cells with singlebroad-based bud –Serology |
|
Treatment for Blasto? |
–Itraconazole –Amphotericinused for severe disease |
|
Where is Coccidioidesimmitis endemic? |
•Endemic in Southwestern U.S. and LatinAmerica |
|
Pathogenesis of Cocci? |
In the lungs, large spherules form and arefilled with endospores–Uponrupture of spherule wall, endosporesare released and differentiate to form new spherules |
|
Clinical manifestations of Cocci? |
Mildinfluenza-like illness with fever and cough (“valley fever”) in 10%•Erythema nodosum seen |
|
Dissemination rate? In what population? Where does it go? |
Dissemination occurs in 1% (AfricanAmericans, Filipinos and women in 3rd trimester of pregnancy atincreased risk) »Bone, meninges and skin |
|
Dx for Cocci? |
–Serology –Spherulesseen microscopically –Eosinophiliais common –Skintest reactivity to diagnose exposure |
|
Treatment for Cocci? |
–Amphotericinfor persistent lung lesions or disseminated disease –Fluconazolefor meningitis •Long term suppression to preventrecurrence |
|
How common of the dimorphic fungi is Paracoccidioidesbrasiliensis? |
Least common |
|
Paracoccidioidesbrasiliensis is endemic where? |
•Rural Latin America, especially Brazil |
|
Clinical manifestations of Paracocci? |
–Mildrespiratoryinfection which can progress with dissemination and development of oral, nasal,and facial nodular ulcerated lesions and submandibular lymphadenopathy. |
|
Diagnosis for Paracocci? |
–Tissuebiopsy shows yeast cells with multiple buds -Serology |
|
Treatment for Paracocci? |
–Severalmonths of Itraconazole –Amphotericinfor severe disease |
|
Configuration of multiple budding Paracocci? |
Pilot wheel configuration |
|
True or false: facial nodules result from Paracocci? |
True |
|
Where do you find Aspergillusfumigatus? |
Worldwide |
|
What is Aspergillus fumigatus? Where does it grow? |
Mold with septate hyphae |
|
On what does Aspergillus fumigatus grow and in what configuration? |
Growthon decaying vegetationproducing chains of conidia |
|
Main features of Aspergillus infection? |
–Fungusball formed within cavities of the lungs; can produce hemoptysis –Allergicinfection of the bronchi that produces asthmatic symptoms and high IgEtiter; causes expectoration of brownish bronchial plugs containing hyphae –InvasivePNA producing hemorrhage, infarction and necrosis, esp. in those withhematologic malignancies and neutropenia (common cause of death) |
|
Diagnosis of Aspergillusfumigatus? |
Biopsy: septate,acute-angle branching hyphae;radiating chains of conidia |
|
Aspergillus CT scan shows what? |
Singleor Multiple nodules with or without cavitation, halo sign (areas of focal hemorrhagearound the lesion) |
|
Aspergillus treatment? Goal of treatment if it forms a fungus ball? For allergic bronchopulmonary apergillosis (ABPA)? |
–1stline treatment: Voriconazole (Amphotericinor echinocandinsare alternative if patients don’t tolerate Vori) –Removethe fungus balls –ForABPA: steroids and antifungalagents |
|
What is Mucormycosis? |
•Opportunistic infection caused bybread mold fungi (Mucor, Rhizopus, Cunninghamella, Lichtheimia) belonging to the family Mucormycetes |
|
Risk factors for mucormycosis infection? |
•Risk factors for infection: Diabetes, neutropenia, iron overload, burns/surgicalwounds, corticosteroid use |
|
How is mucormycosis spread? |
•Transmitted by airborne spores,invades tissues (also angioinvasive) of patients with reduced hostdefenses |
|
Clinical manifestations of mucormycosis? |
–Invasiverhinocerebralsinusitis, frontal lobe abscesses •Originates in the paranasal sinuses and spreads to the orbit,hard palate and brain and carries high mortality rate. •Headache, facial pain –Pneumonia –Cutaneousinfections |
|
How is the configuration of mucormucosis characterized? |
Mucor is characterized by nonseptatebroad hyphae withfrequent right angle branching |
|
Orbital infections in mucormycosis are caused by what? Prognosis? |
Invasive rhinosinusitis. Not good. |
|
Diagnosis of mucormycosis? |
Biopsywith nonseptatebroad hyphae withfrequent right angle branching; spores in a sporangium |
|
Treatment of mucormycosis? |
–Treatthe underlying disorder plus Amphotericinand surgical removal of necrotic infected tissue •Posaconazole can also be used |
|
What is Pneumocystisjiroveci(carinii)? |
Yeast |
|
Symptoms of Pneumocystisjiroveci(carinii) infection? |
•Most infections asymptomatic; 70% of thepopulation has been infected worldwide •Important cause of pneumonia in immunosuppressed (PCP) |
|
What population is Pneumocystisjiroveci very common in, often causing death? |
•Common opportunistic infection andone of the leading causes of death in AIDS patients |
|
Reservoir of Pneumocystisjiroveci transmission? |
Unknown |
|
Describe the pathogenesis of Pneumocystisjiroveci infection? |
•Cysts in alveoli produceinflammatory response, resulting in frothy exudate that blocks oxygen exchange. •Organism does not invade lungtissue. |
|
Why is Pneumocystis jiroveci (PCP) so common in AIDS patients? |
•CD4+ T cells recruit monocytes and macrophages which areresponsible for clearance of the organism –CD4count <200 main risk factor |
|
Clinical manifestations of PCP? |
–Drycough–Dyspneathat is progressive–Fever–Tachypnea–Hypoxemia |
|
Mostcommon CXR findings of PCP? |
Diffuse, bilateral,interstitial, or alveolar infiltratesCXR normal in up to 1/4 |
|
Can Pneumothoraces occur in PCP infection? |
Yes Pneumothoracescan occur |
|
Diagnosis of PCP? |
–Findingcysts by microscopic exam of lung tissue or fluids obtained by bronchoscopy orlung biopsy –Visualizationof cysts by methenaminesilver, Giemsastain or other stains –Flourescentantibody staining –PCRon respiratory tract specimens |
|
PCP treatment? |
•1st line: Trimethoprim-sulfamethoxazole •Other options (2nd line): –Clindamycin/Primaquine–Atovaquone–Pentamidine |
|
What do you give AIDS patients with CD4 count below 200 for prophylaxis against PCP? |
•Prophylaxis for AIDS patients withCD4 count below 200: Bactrim, Dapsone or Atovaquone. |
|
What is Cryptococcus neoformans and where is it found? |
•Yeast present in soil and bird (pigeon) droppings |
|
Describe configuration of Cryptococcus. |
–Ovalbudding yeast with wide polysaccharide capsule; forms narrow-based bud |
|
What does Cryptococcus do in immunocompromised patients? How serious of a problem is it for AIDS patients? |
Causes meningitis inimmunocompromised patients (AIDS especially) and is the most commonlife-threatening disease in AIDS patients. It also causes pneumonia inimmunosuppressed as well as immunocompetent persons.
|
|
Crypto symptoms in immunocompetent patients? Immunosuppressed patients? |
–Vastmajority of immunocompetentpatients will be asymptomatic or have only mild respiratory symptoms. –Inimmunocompromised populations symptoms include fever, chest pain, dyspnea, cough, andhemoptysis |
|
Describe CMV (Cytomegalovirus). |
•DNA enveloped virus similar inmorphology and structure to other Herpes viruses. |
|
Where does CMV infection occur? |
Worldwide |
|
How many infected people have antibodies against CMV? |
80% |
|
Symptoms for CMV infection |
Usually asymptomatic unless immunocompromised
|
|
Pathogenesis of CMV? |
•Enters latent state primarily in monocytes and can be reactivated whencell-mediated immunity is decreased |
|
What does CMV do if you are immunosuppressed? |
•In immunosuppressed population (esp. renal and stemcell transplant recipients), pneumonitis commonly develops –AIDSpatients: colitis and retinitis (typically NOT pneumonitis) |
|
What causes Nocardiosis? |
•Caused by the bacterium Nocardia asteroides |
|
What kind of metabolism does Nocardia asteroides have and where is it found? |
–Aerobes. Found in the soil. |
|
Describe histology of Nocardia. |
–Thinbranching filaments, gram-positive on Gram stain. Many isolates are weakly acid-fast. |
|
What does Nocardia do in the immunocompromised? |
–Inimmunocompromised,produce lung infection and may disseminate – have predilection for brain tissue •Can cause pneumonia, lung abscesswith cavity formation, lung nodules or empyema •Spreads to brain where it causesbrain abscesses |
|
Diagnosis for Nocardia? |
–Diagnosis: gram stain/acid-fast stain; culture |
|
Tx for Nocardia? |
–Treatment: Trimethoprim-sulfamethoxazole •Sometimes combination therapy isneeded •Resistance can occur. Sensitivities should be performed. |